Immunotherapy blocks scarring, improves heart function in mice with heart failure

Researchers at Washington University School of Medicine have reduced scar formation and improved heart function in mouse models of heart failure using a monoclonal antibody treatment. The antibody that reduces inflammation could serve as cardio-immunotherapy for heart failure patients.  Source: WashU Medicine